DEA’s list of timely applicants, dated October 30, 2026, holds 771 applications from California. That’s one for every ten of the state’s 7,692 active cannabis licenses, and 17.4% of the 4,441 active medicinal licenses that could apply. It’s the clearest count yet of how much of California’s market has applied to move into cannabis Schedule 3.
Nationally the list holds 6,983 applications. Oklahoma leads with 2,442. Florida has 812, and California is third with 771.
Has Marijuana Been Rescheduled? Only Part of It
Partly. In April 2026 the Justice Department moved FDA-approved marijuana products, and marijuana handled under a qualifying state medical license, to Schedule III. That order is where the timely-applicant list comes from. Everything else, adult-use cannabis included, is still Schedule I.
Moving the rest of the market is a separate DEA proceeding, and it has stalled. On September 29, the DEA administrative law judge hearing the case paused it to consider a new Government Accountability Office report, which found gaps in the written procedures DEA and FDA follow for scheduling decisions. In October the judge admitted the report but declined to reopen the hearing, with the parties’ final briefs due by November 5. No one can tell you yet when, or whether, adult-use cannabis follows.
California carries a second open question. Most of its medicinal licenses are dual-designated: 3,084 of the 4,441 are Adult-Use and Medicinal. DEA’s guidance doesn’t say how dual licenses fit. Attorneys at Foley Hoag point to a proposed DEA denial of a Minnesota dispensary’s application, not yet final, which says a dual-purpose license may not count as a state medical license at all.
The latest news adds uncertainty rather than removing it. Before you make any judgment, get the facts that apply to your own business.
What the DEA Timely Applicant List Is, and Isn’t
When medical marijuana moved to Schedule III, DEA opened a filing window from April 28 to June 26, 2026, under 21 CFR 1301.13(k)(7). A state-licensed business that filed a complete application, with the fee, inside that window is a timely applicant. It can keep dispensing, manufacturing or distributing under its state medical license while DEA reviews the application.
Every entry is a pending application, not a granted registration. The status ends if the application is withdrawn or denied, or if the business loses its state license. DEA publishes the list with a state, a business activity and a control number for each application. It doesn’t name anyone.
California Applications by Business Activity
|
DEA Schedule III · California
About 1 in 10 active California licenses is on DEA’s timely-applicant list
771 California applications, compared with the active medicinal licenses that could apply and with the whole active market.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
* At most. DEA’s list gives control numbers only, with no business names, so these assume one business per application. Many businesses filed more than one, so the true share is lower.
† Includes cultivation. Under federal law growing counts as manufacturing, and California cultivators applied as manufacturers.
Applications are pending, not granted: they are the applicants DEA lets keep operating while it reviews them. Medicinal means a DCC designation of Medicinal or Adult-Use and Medicinal. Active means Active or Limited Operations.
Sources: DEA Timely Applicant list, 30 Oct 2026 · California DCC license export, 2 Nov 2026 · Bay Kinetic analysis
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Only medicinal businesses could file, so the fair comparison is the 4,441 active licenses that the Department of Cannabis Control (DCC) designates Medicinal, or Adult-Use and Medicinal. Against that pool, applications equal 17.4% of licenses. Against the whole active market, adult-use included, they equal 10.0%.
Dispensaries filed the most: 491 applications against 1,337 active medicinal dispensary licenses, or 36.7%. Distributors filed 82, 11.4% of 722. Manufacturers filed 198, 9.4% of 2,097. Federal law treats growing as manufacturing, so California cultivators applied as manufacturers, and the manufacturer pool includes cultivation licenses. The All row also counts licenses outside the three activities: 285 microbusinesses in the medicinal pool, and in the whole market 345 microbusinesses plus 41 event-organizer and testing-lab licenses. Microbusinesses can dispense, distribute and manufacture, so they don’t fall under a single DEA activity.
Read the Business Shares as a Ceiling
The chart also gives a share of businesses: 771 applications against the 2,917 businesses that hold active medicinal licenses, or 26.4%. Treat that as an upper bound. The list carries no business names, so the figure assumes one business per application. Many businesses filed more than one, so the true share of businesses is lower.
What DEA’s Guidance Asks of Timely Applicants
On Friday, October 30, DEA published the list together with guidance for timely applicants. The core rule: a timely applicant may handle Schedule III medical marijuana only with other timely applicants and with DEA registrants. A state license alone isn’t enough. Dealing with anyone else can be grounds for DEA to deny a pending application or revoke a registration.
DEA expects timely applicants to have verified their existing trading partners, and to have a compliant supply chain, by November 29, 2026. Verification means:
- for a timely dispensary, its Marijuana Dispensary Information Submission confirmation, with a document control number you check on DEA’s Diversion Control site;
- for a timely manufacturer or distributor, its DEA application confirmation, checked the same way;
- for a registrant, a copy of its DEA certificate of registration;
- for everyone, proof that the partner’s state license is active, and a record of what you checked and when.
The list won’t do that work for you. It shows a state, an activity and a control number. It doesn’t show a business name, a DCC license number or anything else that ties an application to a company. You can check a number a partner gives you, but you can’t look a partner up.
Dispensaries and distributors may keep selling inventory they acquired before the guidance, even from partners who aren’t on the list. The guidance doesn’t extend that to manufacturers.
California’s Proposed Rules Arrived the Same Day
Also on October 30, the DCC published proposed rules (DCC-2026-04-R) that would make permanent an expedited way for a licensee holding both the Medicinal and Adult-Use designations to split them into separate licenses, and to put the medicinal license in a different legal entity if it meets the conditions. Emergency rules for this have been in effect since June, and the DCC says 95 licensed businesses have used them to split their licenses. Public comments are open until December 14, with a virtual public hearing on December 15.
Start With One Yes-or-No Question
Ask each of your customers and suppliers:
Are you a DEA timely applicant or a DEA registrant? If yes, please send your DEA confirmation and its control number.
Once you know how many of your trading partners are and aren’t on the list, you can start the cost analysis on what to do next.
Where Your Answers Leave You
All of Them Are on the List
Congratulations. Get a copy of each partner’s DEA confirmation, check its control number against the list, add it to their onboarding file with proof of an active state license, and carry on. Keep your own DCC license current, too: the federal status rests on it, and if the state license lapses the timely-applicant status goes with it.
None of Them Are on the List
If you’re a timely applicant and none of your trading partners are, you can’t keep operating under that status without changing who you do business with. You may want to withdraw your application, unless you believe interstate commerce is coming soon and you can hold on until it does. We don’t think that’s a smart bet. Talk to your lawyer, your lobbyist, and your state and federal representatives before you decide, and don’t bet the farm on it.
Somewhere in the Middle
This is where the hard work is, and it looks different for retailers and producers.
For retailers, getting out from under 280E may pay for the change on its own. Section 280E of the tax code bars businesses that traffic in Schedule I or II substances from deducting ordinary business expenses, so a medical business properly handled under Schedule III, kept apart from adult-use sales, would fall outside it. The numbers above show retailers are the early movers: 36.7% of active medicinal dispensary licenses applied, against about one in ten distributor and manufacturer licenses. Expect some churn on their shelves as they move to buying only from partners who keep them clear of 280E.
For producers (cultivators, extractors and distributors) the choice is harder. Some prepared for this moment and filed in the name of new entities with a clean transaction history. Others will need to restructure to separate their adult-use operations from their timely-applicant operations. How fast that can happen depends on the state and, just as much, on your city and county, which have to approve a new license for the separate operation.
This is general information, not legal or tax advice. Talk to your attorney and your tax advisor before you change your supply chain or your application.
The numbers come from DEA’s Timely Applicant list dated October 30, 2026, and the DCC license export of November 2, 2026. Active means Active or Limited Operations. The DCC’s figure of 95 split licenses is from its Initial Statement of Reasons for DCC-2026-04-R. The other sources are linked in each section.
Are You a Timely Applicant?
Tell us where your DEA application stands. We’ll check it against your California licenses and help you keep the state side in order while DEA reviews it.
